S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
TSE:CPH

Cipher Pharmaceuticals Inc. (CPH.TO) Stock Forecast, Price & News

C$0.88
+0.01 (+1.15 %)
(As of 03/5/2021 03:16 PM ET)
Add
Compare
Today's Range
C$0.87
Now: C$0.88
C$0.89
50-Day Range
C$0.00
MA: C$0.92
C$1.08
52-Week Range
C$0.38
Now: C$0.88
C$1.55
Volume25,546 shs
Average Volume84,152 shs
Market CapitalizationC$23.61 million
P/E Ratio3.11
Dividend YieldN/A
BetaN/A
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BETEFLAM PATCH, a self-adhesive medicated plaster for the treatment of inflammatory skin conditions; BRINAVESS, a treatment for sinus rhythms in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-ISOTRETINOIN; LIPOFEN (CIP-FENOFIBRATE), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and CONZIP/DURELA (CIP-TRAMADOL ER), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include TRULANCE, a once-daily tablet for the treatment of adults with chronic idiopathic constipation and irritable bowel syndrome with constipation; Trevyent, a drug device combination that delivers treprostinil, the treatment for pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for treatment of onychomycosis; and DTR-001 for tattoo removal. The company was founded in 2000 and is headquartered in Oakville, Canada.
Cipher Pharmaceuticals Inc. (CPH.TO) logo

Headlines

Cipher Pharmaceuticals Inc.
January 7, 2021 |  wsj.com
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
August 12, 2020 |  finance.yahoo.com
Cipher Pharmaceuticals, Inc. to Host Earnings Call
March 26, 2020 |  finance.yahoo.com
Notice of Cipher Pharmaceuticals Q4 2019 Conference Call
February 20, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-6025840
Employees6
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$21.37 million
Cash FlowC$0.18 per share
Book ValueC$1.21 per share

Profitability

Miscellaneous

Market CapC$23.61 million
Next Earnings Date3/24/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.82 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
C$0.88
+0.01 (+1.15 %)
(As of 03/5/2021 03:16 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CPH News and Ratings via Email

Sign-up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cipher Pharmaceuticals Inc. (CPH.TO) (TSE:CPH) Frequently Asked Questions

Is Cipher Pharmaceuticals Inc. (CPH.TO) a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cipher Pharmaceuticals Inc. (CPH.TO) in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cipher Pharmaceuticals Inc. (CPH.TO) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CPH, but not buy additional shares or sell existing shares.
View analyst ratings for Cipher Pharmaceuticals Inc. (CPH.TO)
or view top-rated stocks.

What stocks does MarketBeat like better than Cipher Pharmaceuticals Inc. (CPH.TO)?

Wall Street analysts have given Cipher Pharmaceuticals Inc. (CPH.TO) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cipher Pharmaceuticals Inc. (CPH.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cipher Pharmaceuticals Inc. (CPH.TO)'s next earnings date?

Cipher Pharmaceuticals Inc. (CPH.TO) is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Cipher Pharmaceuticals Inc. (CPH.TO)
.

How has Cipher Pharmaceuticals Inc. (CPH.TO)'s stock price been impacted by Coronavirus (COVID-19)?

Cipher Pharmaceuticals Inc. (CPH.TO)'s stock was trading at C$0.74 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CPH shares have increased by 18.9% and is now trading at C$0.88.
View which stocks have been most impacted by COVID-19
.

Who are Cipher Pharmaceuticals Inc. (CPH.TO)'s key executives?

Cipher Pharmaceuticals Inc. (CPH.TO)'s management team includes the following people:
  • Mr. Craig J. Mull, Interim CEO & Chairman
  • Dr. Diane Gajewczyk, VP of Scientific & Medical Affairs
  • Mr. Scott M. Langille CPA, CMA, MBA, Chief Financial Officer (Age 64)

Who are some of Cipher Pharmaceuticals Inc. (CPH.TO)'s key competitors?

What other stocks do shareholders of Cipher Pharmaceuticals Inc. (CPH.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cipher Pharmaceuticals Inc. (CPH.TO) investors own include Cipher Pharmaceuticals (CPHRF), Bellatrix Exploration (BXE), Aurora Cannabis (ACB), (AD), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Catalyst Biosciences (CBIO), Crescent Point Energy (CPG) and Enbridge (ENB).

What is Cipher Pharmaceuticals Inc. (CPH.TO)'s stock symbol?

Cipher Pharmaceuticals Inc. (CPH.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CPH."

How do I buy shares of Cipher Pharmaceuticals Inc. (CPH.TO)?

Shares of CPH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cipher Pharmaceuticals Inc. (CPH.TO)'s stock price today?

One share of CPH stock can currently be purchased for approximately C$0.88.

How much money does Cipher Pharmaceuticals Inc. (CPH.TO) make?

Cipher Pharmaceuticals Inc. (CPH.TO) has a market capitalization of C$23.61 million and generates C$21.37 million in revenue each year.

How many employees does Cipher Pharmaceuticals Inc. (CPH.TO) have?

Cipher Pharmaceuticals Inc. (CPH.TO) employs 6 workers across the globe.

What is Cipher Pharmaceuticals Inc. (CPH.TO)'s official website?

The official website for Cipher Pharmaceuticals Inc. (CPH.TO) is www.cipherpharma.com.

Where are Cipher Pharmaceuticals Inc. (CPH.TO)'s headquarters?

Cipher Pharmaceuticals Inc. (CPH.TO) is headquartered at 2345 Argentia Rd Suite 100A, MISSISSAUGA, ON L5N 8K4, Canada.

How can I contact Cipher Pharmaceuticals Inc. (CPH.TO)?

Cipher Pharmaceuticals Inc. (CPH.TO)'s mailing address is 2345 Argentia Rd Suite 100A, MISSISSAUGA, ON L5N 8K4, Canada. The company can be reached via phone at +1-905-6025840.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.